skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi Peter.. I hold the above stocks and would like to lower my exposure to the sector due to the volatility, what would be the weakest link of the group? Thank you Anthony
Read Answer Asked by Anthony on January 11, 2016
Q: Further to Arnold's question today, would you be confident in adding to a position in RX now? I have held it for quite a while and also observed the flat price curve; and have been pondering sell or add.
As technicians look at the RX chart, would they be thinking a "breakout" to the upside as more likely than to the downside especially when coupled with the metrics you and Arnold mentioned?

And of course suggest buying more?

Thanks.
Read Answer Asked by Donald on January 10, 2016
Q: I purchased this company before joining 5i Research. It is turning out to be fraught with lots of problems, the most current being that they have received a letter from NYSE regulation stating that they are not in compliance due to the company's failure to timely file its 3Q report. If they don't respond by Feb. 5th the co. could be de-listed from the NYSE. So what to do with this stock at this stage? Hold or cut my losses?
Read Answer Asked by Jen on January 10, 2016
Q: I am wondering why you think biosyent hasn't moved in the past six months, depute excellent growth in revenue and earnings, ROE above 40%, no debt, and new products coming on stream. Any thoughts?
Read Answer Asked by arnold on January 08, 2016
Q: What do you think about the management changes announced today? Is it a sign of accounting manipulation of any sort?

Thanks
Read Answer Asked by Febin on January 07, 2016
Q: Happy New Year Peter and staff. Nobilis shareholders are involved in a law suit in U.S. Do you feel I should get out now or wait it out. There is no loss now but it can be so messy! Thanks your you expert insight. Rossana
Read Answer Asked by Rossana on January 06, 2016
Q: Hi folks,can u please comment on re-statement of financials for Nhc/t.Is this good or bad,and long term,is this stock a buy,hold or total avoid. Thanks as always
Read Answer Asked by John on January 06, 2016
Q: Happy New Year to the 5i Team,
I found your answer to the question regarding PHM`s year end results to be clear, factual, but guarded; understandable, considering the dramatic start to this morning`s opening of the North American markets. By the end of the day, the stock went up 25% with huge volume. I am currently with BMO Investorline, who are on record as stating that ``There are currently no news headlines for this security`. Without overstating the obvious, would you be able to offer any further observations or feedback after today`s results, on an otherwise gloomy day? I find it hard to believe that there has not been more interest shown by other members in this event. Thank you as always. Rick
Read Answer Asked by Rick on January 05, 2016
Q: Happy New Year to all. Could have your opinion of the merger of agn and pfe. and a 1 year outlook for agn.
Read Answer Asked by kenneth on January 04, 2016
Q: Is Cipher a good deal at it's current price? Can you update us on your view of this company?
Read Answer Asked by Grant on January 04, 2016
Q: Could you please comment on $CRH for a medium term hold, thanks Valter
Read Answer Asked by Valter on December 29, 2015
Q: Seasons Greetings!!!
Your last comment on Horizon Pharma was Feb/15. Could I have your current opinion please?
Thanks
Dave
Read Answer Asked by Dave on December 24, 2015
Q: The latest update on NHC delay in filing their financial statements seems to include a new issues of concern including accounting for warrants and option issued in the past, compensation matters and even calculations of fully diluted shares. A month after missing their filing date, there doesn't seem to be much progress and instead a number of new issues. Do you think the red flags are waving?
Read Answer Asked by Kent on December 24, 2015
Q: My question pertains to the loan Gud made to Extenway in June 2015. After looking at the Extenway financials I am perplexed to find a reason why GUD management would have entered into such an agreement in the first place. If their loan portfolio is anywhere close to this transaction I think there is a serious problem. Could I get your thoughts on this one.
Read Answer Asked by roland on December 22, 2015
Q: Now that they have started phase 1 trials with md Anderson, do you have any change to your view on the company??
Read Answer Asked by Bill on December 21, 2015
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!